An IgG4 Anti-Human Endogenous Retrovirus Monoclonal Antibody
Temelimab, an IgG4 Anti-Human Endogenous Retrovirus Monoclonal Antibody: An Early Progress Safety Evaluation Introduction:Â Temelimab (beforehand often called GNbAC1) is an immunoglobulin (Ig) G4 monoclonal antibody that targets the human endogenous retroviral envelope protein HERV-W-Env, confirmed…Continue Reading